48,847
edits
(→Grading: wikify) |
(→IHC: wikify) |
||
Line 62: | Line 62: | ||
*Cytokeratins ~70% +ve.{{fact}} | *Cytokeratins ~70% +ve.{{fact}} | ||
*SOX10 +ve.<ref name=pmid18636017>{{cite journal |author=Nonaka D, Chiriboga L, Rubin BP |title=Sox10: a pan-schwannian and melanocytic marker |journal=Am. J. Surg. Pathol. |volume=32 |issue=9 |pages=1291–8 |year=2008 |month=September |pmid=18636017 |doi=10.1097/PAS.0b013e3181658c14 |url=}}</ref> | *SOX10 +ve.<ref name=pmid18636017>{{cite journal |author=Nonaka D, Chiriboga L, Rubin BP |title=Sox10: a pan-schwannian and melanocytic marker |journal=Am. J. Surg. Pathol. |volume=32 |issue=9 |pages=1291–8 |year=2008 |month=September |pmid=18636017 |doi=10.1097/PAS.0b013e3181658c14 |url=}}</ref> | ||
**-ve in synovial sarcoma, rhabomyosarcoma, chondrosarcoma. | **-ve in [[synovial sarcoma]], [[rhabomyosarcoma]], [[chondrosarcoma]]. | ||
==Traumatic neuroma== | ==Traumatic neuroma== |
edits